Discovery of the First Potent DYRK2 Proteolysis Targeting Chimera Degraders

Jian Chen1, Wentao Zhu1, Wenqian Zhang1

  • 1School of Chemistry, Sun Yat-sen University, Guangzhou 510275, China.

Insights

Researchers developed the first proteolysis-targeting chimeras (PROTACs) to degrade Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2), a cancer target. The compound CP134 effectively reduced DYRK2 levels via the ubiquitin-proteasome system.

Area of Science:

  • Oncology
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • DYRK2 is an oncogenic driver in multiple cancers, making it a key therapeutic target.
  • Existing DYRK2 inhibitors are available, but no degraders have been developed.
  • Targeting protein degradation offers a novel therapeutic strategy.

Purpose of the Study:

  • To design and synthesize the first series of PROTACs targeting DYRK2.
  • To evaluate the efficacy of these PROTACs in degrading DYRK2.
  • To investigate the mechanism of action for DYRK2 degradation.

Main Methods:

  • PROTACs were designed using curcumin analogs as warheads.
  • Degradation assays were performed to assess intracellular DYRK2 levels.
  • Mechanism of action studies utilized the ubiquitin-proteasome system.

Main Results:

  • The compound CP134 effectively degraded intracellular DYRK2 with a DC50 of 1.607 μM.
  • CP134-induced degradation of DYRK2 occurred via the ubiquitin-proteasome pathway.
  • This study presents the first potent DYRK2 degrader.

Conclusions:

  • CP134 is the first identified potent degrader of DYRK2.
  • CP134 serves as a valuable chemical tool for exploring DYRK2's therapeutic potential.
  • This work expands the application of PROTACs to new substrate targets.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...